These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21760575)

  • 1. Amyloid: little proteins, big clues.
    Schnabel J
    Nature; 2011 Jul; 475(7355):S12-4. PubMed ID: 21760575
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamics of plaque formation in Alzheimer's disease.
    Urbanc B; Cruz L; Buldyrev SV; Havlin S; Irizarry MC; Stanley HE; Hyman BT
    Biophys J; 1999 Mar; 76(3):1330-4. PubMed ID: 10049316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
    Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
    Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicine. Prion-like behavior of amyloid-beta.
    Kim J; Holtzman DM
    Science; 2010 Nov; 330(6006):918-9. PubMed ID: 21071652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of aggregation.
    Nat Neurosci; 2011 Apr; 14(4):399. PubMed ID: 21445061
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.
    Eisele YS; Obermüller U; Heilbronner G; Baumann F; Kaeser SA; Wolburg H; Walker LC; Staufenbiel M; Heikenwalder M; Jucker M
    Science; 2010 Nov; 330(6006):980-2. PubMed ID: 20966215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual severity of AD-type lesions, Aß oligomers, and comorbidity in the brain aging.
    Bouras C; Kovari E; Savioz A; Giacobini E; Xekardaki A
    Adv Exp Med Biol; 2015; 822():17. PubMed ID: 25416972
    [No Abstract]   [Full Text] [Related]  

  • 11. Amyloid by default.
    Walker LC; Jucker M
    Nat Neurosci; 2011 Jun; 14(6):669-70. PubMed ID: 21613991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.
    Díaz-Nido J; Wandosell F; Avila J
    Peptides; 2002 Jul; 23(7):1323-32. PubMed ID: 12128089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing the growth of Alzheimer's A beta amyloid-like fibrils.
    Goldsbury C; Aebi U; Frey P
    Trends Mol Med; 2001 Dec; 7(12):582. PubMed ID: 11733223
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.
    Meyer-Luehmann M; Spires-Jones TL; Prada C; Garcia-Alloza M; de Calignon A; Rozkalne A; Koenigsknecht-Talboo J; Holtzman DM; Bacskai BJ; Hyman BT
    Nature; 2008 Feb; 451(7179):720-4. PubMed ID: 18256671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The search for an amyloid solution.
    Robinson SR; Bishop GM
    Science; 2002 Nov; 298(5595):962-4; author reply 962-4. PubMed ID: 12416505
    [No Abstract]   [Full Text] [Related]  

  • 18. Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology.
    Leuba G; Saini K; Savioz A; Charnay Y
    JAMA; 2000 Apr; 283(13):1689-91. PubMed ID: 10755493
    [No Abstract]   [Full Text] [Related]  

  • 19. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
    Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice.
    Song PJ; Bernard S; Sarradin P; Vergote J; Barc C; Chalon S; Kung MP; Kung HF; Guilloteau D
    Nucl Med Biol; 2008 Feb; 35(2):197-201. PubMed ID: 18312829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.